Bernhard Schlevogt
Has participated in:
-
Comparative analysis of SEC61A1 mutant R236C in two patient-derived cellular platforms
-
A SEC61A1 variant is associated with autosomal dominant polycystic liver disease
-
Weight gain after interferon-free treatment of chronic hepatitis C — results from the German Hepatitis C-Registry (DHC-R)
-
Weight Gain after Interferon-Free Treatment of Chronic Hepatitis C—Results from the German Hepatitis C-Registry (DHC-R)